These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8326736)

  • 1. A new pharmacological activity of dibutyl phthalate (DBP) on selective elimination of tumor cells from bone marrow.
    Wu CT; Pei XT; Cao JR; Xue HH
    Leuk Res; 1993 Jul; 17(7):557-60. PubMed ID: 8326736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow purging with dibutyl phthalate--experimental basis and a preliminary clinical application.
    Wu C; Yang K; Pei X; Tang A; Wang F; Wang L
    Leuk Res; 1995 Aug; 19(8):557-60. PubMed ID: 7658702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of doxorubicin in combination with mafosfamide for in vitro elimination of myeloid and lymphoid tumor cells from human bone marrow.
    Domenech J; Georget MT; Gihana E; Colombat P; Brémond JL; Chassaigne M; Lamagnère JP; Binet C
    Bone Marrow Transplant; 1992 Feb; 9(2):101-6. PubMed ID: 1571708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purging effect of dibutyl phthalate on leukemic cells associated with apoptosis.
    Lisheng W; Chutse W; Xuetao P; Li X; Jurong C; Fuchu H
    Leuk Res; 1996; 20(11-12):989-92. PubMed ID: 9009259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of dibutyl phthalate on the proliferation and apoptosis of leukemic cells].
    Wan W; Xu Y; Jiang D
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(2):137-40. PubMed ID: 10681825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanisms of dibutyl phthalate to purge leukemic cells].
    Wan WQ; Liu XY; Deng B
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Feb; 29(1):79-80. PubMed ID: 16137013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory activity of endogenous MIP-1 alpha in long-term cultures of human marrow.
    Cashman JD; Eaves AC; Wolpe S; Eaves CJ
    Prog Clin Biol Res; 1994; 389():261-8. PubMed ID: 7700910
    [No Abstract]   [Full Text] [Related]  

  • 8. Dibutyl phthalate purged autologous bone marrow transplant in the treatment of leukemia.
    Wang L; Wu C; Pei X; Xu L; Cao J; Xue H; Yang K; Teng A; Ji S
    Leuk Res; 1996 Apr; 20(4):343-8. PubMed ID: 8642846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proliferation and differentiation of cells and differentiation- inducing treatment in leukemia].
    Kuliczkowski K
    Pol Arch Med Wewn; 1992 Jul; 88(1):49-56. PubMed ID: 1454660
    [No Abstract]   [Full Text] [Related]  

  • 10. Suitability of a new stable acetal analogue of aldoifosphamide for purging leukemic cells from human bone marrow.
    Andersson BS; Wang YQ; McCredie KB; Farquhar D
    Leukemia; 1990 Jun; 4(6):435-40. PubMed ID: 2359343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
    Gidáli J; Fehér I; Kovács P
    Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood.
    Strife A; Lambek C; Perez A; Darzynkiewicz Z; Skierski J; Gulati S; Haley JD; ten Dijke P; Iwata KK; Clarkson BD
    Cancer Res; 1991 Sep; 51(18):4828-36. PubMed ID: 1893375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentoxifylline synergizes with all-trans retinoic acid to induce differentiation of HL-60 myelocytic cells, but suppresses tRA-augmented clonal growth of normal CFU-GM.
    Yang KD; Chao CY; Shaio MF
    Acta Haematol; 1998; 99(4):191-9. PubMed ID: 9644296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage.
    Wierenga PK; Konings AW
    Exp Hematol; 1996 Feb; 24(2):246-52. PubMed ID: 8641348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purine nucleotide biosynthesis in leukemic promyelocytes treated with retinoids.
    Tsutani H; Kagawa D; Uchida M; Yoshimura T; Tanaka T; Ueda T; Nakamura T
    Adv Exp Med Biol; 1991; 309A():79-82. PubMed ID: 1789274
    [No Abstract]   [Full Text] [Related]  

  • 17. Preferential suppression of low molecular weight natural tumor suppressor of human fetal liver origin on the growth of leukemic cells in vitro.
    Pei XT; Wu CT
    Exp Hematol; 1990 Sep; 18(8):927-31. PubMed ID: 2387343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bryostatin-5 stimulates normal human hematopoiesis and inhibits proliferation of HL60 leukemic cells.
    van der Hem KG; Dräger AM; Odding JH; Langenhuijsen MM; Huijgens PC
    Leuk Res; 1995 Jan; 19(1):7-13. PubMed ID: 7837820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferation of hemopoietic stem cells and development of potentially leukemic cells in vitro.
    Dexter TM; Laijtha LG
    Bibl Haematol; 1975 Oct; (43):1-5. PubMed ID: 1085618
    [No Abstract]   [Full Text] [Related]  

  • 20. Elimination of leukemic cells by laser photodynamic therapy.
    Gulliya KS; Fay JW; Dowben RM; Berkholder S; Matthews JL
    Cancer Chemother Pharmacol; 1988; 22(3):211-4. PubMed ID: 3165726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.